Abstract:Cardiac glycogen regulation involves a complex interplay between multiple signalling pathways, allosteric activation of enzymes, and sequestration for autophagic degradation. Signalling pathways appear to converge on glycogen regulatory enzymes via insulin (glycogen synthase kinase 3, protein phosphatase 1, allosteric action of glucose-6-phosphate), -adrenergic (phosphorylase kinase protein phosphatase 1 inhibitor), and 5 adenosine monophosphate-activated protein kinase (allosteric action of glucose-6-phosphate, direct glycogen binding, insulin receptor). While cytosolic glycogen synthesis and breakdown are relatively well understood, recent findings relating to phagic glycogen degradation highlight a new area of investigation in the heart. It has been recently demonstrated that a specific glycophagy pathway is operational in the myocardium. Proteins involved in recruiting glycogen to the forming phagosome have been identified. Starch-binding domain-containing protein 1 is involved in binding glycogen and mediating membrane anchorage via interaction with a homologue of the phagosomal protein light-chain 3. Specifically, it has been shown that starch-binding domain-containing protein 1 and light-chain 3 have discrete phagosomal immunolocalization patterns in cardiomyocytes, indicating that autophagic trafficking of glycogen and protein cargo in cardiomyocytes can occur via distinct pathways. There is strong evidence from glycogen storage diseases that phagic/lysosomal glycogen breakdown is important for maintaining normal cardiac glycogen levels and does not simply constitute a redundant alternative' breakdown route for glycogen. Advancing understanding of glycogen handling in the heart is an important priority with relevance not only to genetic glycogen storage diseases but also to cardiac metabolic stress disorders such as diabetes and ischaemia.

From Prokaryotes to Eukaryotes: Insights Into the Molecular Structure of Glycogen Particles

Molecular Structure of Glycogen in Escherichia coli

Recent developments in our understanding of glycogen structure

Molecular mechanisms of glycogen particle assembly in Escherichia coli

Glycogen metabolism and structure: A review

Molecular Structure of Human-Liver Glycogen

Molecular structure of glycogen in diabetic liver

Normal and abnormal glycogen structure - A review

The importance of glycogen molecular structure for blood glucose control

The dynamic changes of glycogen molecular structure in Escherichia coli BL21(DE3)

Improving human health through understanding the complex structure of glucose polymers

The Molecular Background of Glycogen Metabolism Disorders

Biochemical and clinical aspects of glycogen storage diseases

Molecular exploration of the diurnal alteration of glycogen structural fragility and stability in time-restricted-feeding mouse liver

Brain glycogen: A key to revealing the pathology of mental diseases

Myocardial glycogen dynamics: new perspectives on disease mechanisms.

The Sweetest Polymer Nanoparticles: Opportunities Ahead for Glycogen in Nanomedicine

Mechanism of glycogen synthase inactivation and interaction with glycogenin

Size-separation characterization of starch and glycogen for biosynthesis–structure–property relationships

Comparative transcriptome analysis of diurnal alterations of liver glycogen structure: A pilot study

Using molecular fine structure to identify optimal methods of extracting fungal glycogen